BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anthem Biosciences IPO is Open!
Apply for the Anthem Biosciences IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Aakaar Medical Technologies Ltd

Healthcare

Offer Period :

20th to 24th Jun 2025

Aakaar Medical Technologies Ltd IPO Details

IPO Date 20th to 24th Jun 2025 Minimum Investment ₹115200 / 2 Lots
Listing Date 2025-06-27 Maximum Investment ₹115200 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹27 Crores
Price ₹72 to ₹72 per share Fresh Issue ₹27 Crores
Lot Size 1 Lots (1600 Shares) Offer For Sale ₹ [-]
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 10422416 Shares
Issue Type Book Building - SME Shareholding Post Issue 14172816 Shares
IPO Date 20th to 24th Jun 2025
Listing Date 2025-06-27
Face Value ₹10 per share
Price ₹72 to ₹72 per share
Lot Size 1 Lots (1600 Shares)
Listing At NSE-SME
Total Issue Size ₹27 Crores
Employee Discount ₹0 per share
Issue Type Book Building - SME
Minimum Investment ₹115200 / 2 Lots
Maximum Investment ₹115200 / 1 Lots
Fresh Issue ₹27 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 10422416 Shares
Shareholding Post Issue 14172816 Shares

About Aakaar Medical Technologies Ltd IPO

Incorporated in June 2013, Aakaar Medical Technologies Limited operates as a medical aesthetics company, offering a wide range of specialised cosmetic products and devices. The company's portfolio includes both its own branded products—manufactured domestically through loan licensing or third-party arrangements—and a selection of imported brands sourced from countries such as South Korea, Spain, Italy, and Austria. These products are primarily supplied to professionals in the aesthetic space, including dermatologists, plastic surgeons, and aesthetic physicians, who either use them in treatments or resell them to end consumers.
 

Aakaar’s product range covers categories such as homecare and professional skincare, injectable and contouring solutions, hair growth serums and tablets, medifacial kits, and specialised devices for treatments like laser hair reduction, skin rejuvenation, and tattoo removal. With a nationwide presence and a team of 90 trained sales and service engineers, the company supplies to multiple Indian states including Delhi, Maharashtra, West Bengal, Tamil Nadu, and others.

Founding Year: 2013

Managing Director: Dilip Ramesh Meswani

Aakaar Medical Technologies Limited Timeline

Important dates for allocation and IPO listing.

20th Jun

IPO Opens

24th Jun

IPO Close

25th Jun

Allotment Date

26th Jun

Initiation of Refund

26th Jun

Credit of Shares to Demat Account

27th Jun

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 91.11 67.01
Public Group 8.89 32.99

Aakaar Medical Technologies Ltd IPO Reservation

QIB Shares Offered 712000(18.98%)
NII (HNI) Shares Offered 534400(14.25%)
Retail Shares Offered 1248000(33.28%)
Anchor Investor Shares Offered 1067200(28.46%)
Total Shares Offered 3750400
Total Shares With Anchor Investor 3750400

Aakaar Medical Technologies Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 ₹115200
Retail (Max) 1 1600 ₹115200
S HNI (Min) 2 3200 ₹230400
S HNI (Max) 8 12800 ₹921600
B HNI (MIN) 9 14400 ₹1036800

Aakaar Medical Technologies Ltd IPO Anchor Investor Details

Bid Date 19 June 2025
Shares Offered 0
Anchor Portion Size 0

Aakaar Medical Technologies Ltd IPO Registrar

Bigshare Services Pvt Ltd
Phone Number +91 22 62638200
Email Id ipo@bigshareonline.com
Our Website www.bigshareonline.com

Aakaar Medical Technologies Ltd IPO Lead Manager

1. Indorient Financial Services Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Aakaar Medical Technologies Ltd Financial Information

Period Ended March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹23.2 ₹12.54 ₹9.66
Reserves and Surplus ₹12.78 ₹11.84 ₹8.96
Total Borrowing ₹22.74 ₹15.06 ₹5.87

Aakaar Medical Technologies Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 712000 2496000 3.5056
Non Institutional Investors (NIIs) 534400 982400 1.8383
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 534400 0 0
Retail Individual Investors (RIIs) 1248000 2411200 1.9321
Total 2683200 5889600 2.195

Strength of Aakaar Medical Technologies Ltd

1. Experienced management and leadership teams.

2. Diversified customer base.

3. Diversified product base.

4. Pan India reach through its consignment sales partner.

Risks Involved

1. A substantial portion of the revenue is derived from sale of imported third party manufactured brands which exposes it to various risk.

2. The company relies on third party contract manufacturers (domestic and international) & loan licensing partners for manufacturing products & devices which of the sell under its own Brand. the company dependence on third-party manufacturers for the manufacturing of all the products subjects it to certain risks, which, if realized, could adversely affect its business, results of operations, cash flows and financial condition.

3. The company registered office is situated in Maharashtra and the derive a significant portion of the company revenue from state of Maharashtra and Karnataka, making it vulnerable to geographical concentration risk.

4. The company has appointed Parekh Integrated Services Private Limited (PISPL) as a CSA agent for storing, delivering and distributing its products & recovery of dues. Any non-performance or breach of covenants of the CSA agreement executed with PISPL may adversely affect its business operations, profitability and cash flows.

5. Failures to identify and effectively respond to changing consumer preferences, consumer behaviour and spending patterns or changing beauty and personal care trends in a timely manner, may adversely affect the demand for the company products, causing its business, results of operations, financial condition and cash flows.

6. The company may not be able to accurately manage the company inventory, this may adversely affect its business, financial condition and results of operations and reputation.

7. The Company has reported negative cash flow in the past. Any negative cash flows in the future would adversely affect the cash flow requirements, which may adversely affect the company ability to operate the company business and implement its growth plans, thereby affecting its financial condition.

8. As the market for aesthetic treatments grows, the number of clinics and practitioners offering these services is increasing in India which may increase competition among clinics leading to competitive pricing of products. Any change in product pricing will impact revenue and profitability of the business.

9. Its may be subject to unfair competitive or trade practices, like the availability of counterfeit injectables, skincare products, and aesthetic devices, which may reduce the company sales and harm its brands, adversely affecting the company business, financial condition, cash flows and results of operations.

10. Invasive and non-invasive procedures alike carry risks, including infections, scarring, and unintended aesthetic outcomes which may deter the patients from seeking treatments and impact the demand for the products and devices used for these treatments.

Why should you invest in

-

Aakaar Medical Technologies Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Aakaar Medical Technologies Limited IPO Contact Details

Aakaar Medical Technologies Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-06-27 94576 AAKAAR
INE1GYP01013
₹72 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹72 ₹72
Open ₹0 ₹75
Low ₹0 ₹71.25
High ₹0 ₹75
Low ₹0 ₹71.25

Industry Outlook of Aakaar Medical Technologies IPO

  • The global market for medical aesthetics and cosmetic dermatology was valued at USD 35.9 billion in calendar year (CY) 2024.

  • It is anticipated to grow and reach USD 57.4 billion by CY2030.

  • The Indian segment of this market recorded a revenue of USD 283.9 million in CY2024.

  • It is expected to grow at a compound annual growth rate (CAGR) of 13.9% during the forecast period.

  • By CY2030, India’s market revenue is estimated to reach USD 618.8 million.

  • The global market growth is influenced by ongoing technological developments.

  • Increasing consumer interest in aesthetic procedures is contributing to the upward trend.

  • A wider social and cultural acceptance of cosmetic treatments is also playing a role in market expansion.

  • Both global and Indian markets are expected to evolve steadily in response to these contributing factors.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Aakaar Medical Technologies IPO.

Frequently Asked Questions

What is Aakaar Medical Technologies Ltd IPO?

Answer Field

Aakaar Medical Technologies Ltd IPO is a SME IPO of 37,50,400 equity shares of a face value of ₹10 aggregating up to ₹27 Crores. The issue is priced at ₹72 to ₹72 per share. The minimum order quantity is 1600 Shares. The IPO opens on June 20, 2025, and closes on June 24, 2025. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Aakaar Medical Technologies Ltd IPO will open?

Answer Field

The Aakaar Medical Technologies Ltd IPO opens on June 20, 2025 and closes on June 24, 2025.

What is the lot size of Aakaar Medical Technologies Ltd?

Answer Field

Aakaar Medical Technologies Ltd lot size is 1600 shares, and the minimum amount required is ₹1,15,200.

How to apply for Aakaar Medical Technologies Ltd IPO?

Answer Field

You can apply in Aakaar Medical Technologies Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Aakaar Medical Technologies Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Aakaar Medical Technologies Ltd IPO will be done on June 25, 2025, and the allotted shares will be credited to your demat account by June 26, 2025.

When is Aakaar Medical Technologies Ltd IPO listing date?

Answer Field

The Aakaar Medical Technologies Ltd listing date is June 27, 2025.

Who is the registrar of Aakaar Medical Technologies Ltd IPO?

Answer Field

The registrar of Aakaar Medical Technologies Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Indorient Financial Services Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Aakaar Medical Technologies Ltd IPO?

Answer Field

The fresh issue size is ₹27 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Aakaar Medical Technologies Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹1,15,200 amount.

How can I approve the UPI mandate request for Aakaar Medical Technologies Ltd IPO?

Answer Field

To apply for Aakaar Medical Technologies Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Aakaar Medical Technologies Ltd?

Answer Field

The price of each Aakaar Medical Technologies Ltd share will be ranging in between ₹72 to ₹72 per share.

What is the cut-off time for the UPI mandate for Aakaar Medical Technologies Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, June 24, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • ANTHEM BIOSCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹540.0 - 570.0

  • IPO Size

    ₹33,95,00,00,000

  • Apply Now
  • SPUNWEB NONWOVEN LIMITEDSME IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹90.0 - 96.0

  • IPO Size

    ₹60,98,00,000

  • Apply Now
  • MONIKA ALCOBEV LIMITEDSME IPO

  • Bidding Dates

    16th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹271.0 - 286.0

  • IPO Size

    ₹1,53,68,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Bidding Dates

    2nd Jul 2025 - 7th Jul 2025

  • Price Range

    ₹233.0 - 245.0

  • IPO Size

    ₹8,60,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Issue Price

    245.00

  • Listing Day Close

    307.45

  • Listing Day (Gain/Loss)

    25.31

  • VANDAN FOODS LIMITEDSME IPO

  • Issue Price

    115.00

  • Listing Day Close

    118.75

  • Listing Day (Gain/Loss)

    3.48

  • NEETU YOSHI LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    46.67

  • PRO FX TECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    99.75

  • Listing Day (Gain/Loss)

    14.94

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text